According to the National Cancer Institute, colorectal cancer is the fourth most frequently diagnosed cancer in the United States, with approximately 52,550 deaths from the disease occurring in 2023. As the nation spotlights colorectal cancer awareness this March, test your knowledge here!
References
- Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA. 2012;308(5):485-492. doi:10.1001/jama.2012.8780
- Motta R, Cabezas-Camarero S, Torres-Mattos C, et al. Personalizing first-line treatment in advanced colorectal cancer: present status and future perspectives. J Clin Transl Res. 2021;7(6):771-785.
- Lu X, Li Y, Li Y, et al. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC Cancer. 2023;23(1):1117. doi:10.1186/s12885-023-11600-z
- Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509-2520. doi:10.1056/NEJMoa1500596
- Benson AB, Venook AP, Al-Hawary MM, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359-369. doi:10.6004/jnccn.2018.0021